In this respect it is interesting that co-expression of Sox2, Oct4 and Nanog primarily could be detected in highly malignant forms of gliomas and that downstream target genes of these transcription factors in ES-cells, frequently are overexpressed in poorly differentiated tumors including glioblastomas [16]. The gene discussed is SOX2; the disease is central nervous system cancer.